169 related articles for article (PubMed ID: 20204504)
1. Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease.
Shinmura K
Heart Fail Rev; 2010 Sep; 15(5):457-66. PubMed ID: 20204504
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
4. Total and high molecular weight adiponectin levels in the rat model of post-myocardial infarction heart failure.
Kalisz M; Baranowska B; Wolinska-Witort E; Maczewski M; Mackiewicz U; Tulacz D; Gora M; Martynska L; Bik W
J Physiol Pharmacol; 2015 Oct; 66(5):673-80. PubMed ID: 26579573
[TBL] [Abstract][Full Text] [Related]
5. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
[TBL] [Abstract][Full Text] [Related]
6. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.
Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Mogelvang R
Eur J Heart Fail; 2014 Jun; 16(6):633-8. PubMed ID: 24723498
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin: from obesity to cardiovascular disease.
Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C
Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin actions in the cardiovascular system.
Hopkins TA; Ouchi N; Shibata R; Walsh K
Cardiovasc Res; 2007 Apr; 74(1):11-8. PubMed ID: 17140553
[TBL] [Abstract][Full Text] [Related]
10. Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.
Parajuli N; Patel VB; Wang W; Basu R; Oudit GY
Clin Sci (Lond); 2014 Sep; 127(5):331-40. PubMed ID: 24624929
[TBL] [Abstract][Full Text] [Related]
11. Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure.
Lee R; Xu B; Rame JE; Felkin LE; Barton P; Dries DL
J Am Heart Assoc; 2014 Dec; 3(6):e001104. PubMed ID: 25516437
[TBL] [Abstract][Full Text] [Related]
12. ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity.
Patel VB; Mori J; McLean BA; Basu R; Das SK; Ramprasath T; Parajuli N; Penninger JM; Grant MB; Lopaschuk GD; Oudit GY
Diabetes; 2016 Jan; 65(1):85-95. PubMed ID: 26224885
[TBL] [Abstract][Full Text] [Related]
13. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
14. Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue.
Niemann B; Pan R; Teschner M; Boening A; Silber RE; Rohrbach S
Exp Gerontol; 2013 Jan; 48(1):55-63. PubMed ID: 22546364
[TBL] [Abstract][Full Text] [Related]
15. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure.
Wannamethee SG; Whincup PH; Lennon L; Sattar N
Arch Intern Med; 2007 Jul; 167(14):1510-7. PubMed ID: 17646605
[TBL] [Abstract][Full Text] [Related]
16. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality.
Menzaghi C; Trischitta V
Diabetes; 2018 Jan; 67(1):12-22. PubMed ID: 29263167
[TBL] [Abstract][Full Text] [Related]
17. Increased myocardial ischemia-reperfusion injury in renal failure involves cardiac adiponectin signal deficiency.
Song Y; Yu Q; Zhang J; Huang W; Liu Y; Pei H; Liu J; Sun L; Yang L; Li C; Li Y; Zhang F; Qu Y; Tao L
Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1055-64. PubMed ID: 24595307
[TBL] [Abstract][Full Text] [Related]
18. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study.
Haugen E; Furukawa Y; Isic A; Fu M
Int J Cardiol; 2008 Apr; 125(2):216-9. PubMed ID: 18234365
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.
Shibata R; Sato K; Pimentel DR; Takemura Y; Kihara S; Ohashi K; Funahashi T; Ouchi N; Walsh K
Nat Med; 2005 Oct; 11(10):1096-103. PubMed ID: 16155579
[TBL] [Abstract][Full Text] [Related]
20. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
